Working for you in North America

With more than 65,000 active clinical trials and the largest market for drug and medical device products, North America is a very important region to life science firms (regardless of their location). Our team provides the right expert guidance and operational execution across the spectrum of drug and medical device development - from regulatory strategies and filings to clinical development to GxP compliance, and post-marketing research.

We are headquartered in Research Triangle Park, NC, USA, with additional offices in Overland Park, Kansas and Boulder, Colorado. Within these offices we deliver a full array of outsourced regulatory, strategic development, clinical development, and post-approval services.

North American Services & Experience At-A-Glance:

Local Services

By Therapeutic Area

By Phase

  • Oncology: 33%
  • Central Nervous System: 11%
  • Cardio/Metabolism: 10%
  • Dermatology: 7%
  • Orthopedic: 6%
  • Infectious Diseases: 6%
  • Gastroenterology: 6%
  • Rheumatology: 4%
  • Eye and Ear: 4%
  • Nephrology/Renal: 3%
  • Immunology: 3%
  • Other: 4%
  • Phase 1: 16%
  • Phase 2: 28%
  • Phase 3: 20%
  • Phase 4: 15%
  • Registry: 16%
  • Other: 5%


Clinipace Worldwide Acquires Paragon Biomedical, Inc.

Clinipace Worldwide and Paragon Biomedical, Inc. today jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired the privately-held, Irvine, CA-based company and its subsidiaries. The acquisition further expands Clinipace’s therapeutic expertise, site management capabilities, and global footprint.

Clinipace Worldwide
© 2013 CLINIPACE. All Rights Reserved. Website Privacy Statement | US-EU Safe Harbor | eLinks